An alternative conditioning regimen for induction of specific skin graft tolerance across full major histocompatibility complex barriers

By de Vries-van der Zwan A.   van der Pol M.A.   de Waal L.P.   Boog C.J.  

Transplant Immunology, Vol. 6, Iss. 3, 1998-09 ,pp. : 147-151

Elsevier

Access to resources Recommend Favorite

Role of microchimerism on long-term graft survival after donor-specific transfusion in a rat heart transplantation model

By Ito H.   Hamano K.   Gohra H.   Katoh T.   Fujimura Y.   Zempo N.   Esato K.  

Transplantation Proceedings, Vol. 30, Iss. 7, 1998-11 ,pp. : 3862-3864

Elsevier

Access to resources Recommend Favorite

Mechanism of portal venous tolerant long-term MHC Class I L d -specific skin graft survival in transgenic 2CF1 mice

By Margenthaler J.A.   Landeros K.   Kataoka M.   Flye M.W.  

Transplant Immunology, Vol. 11, Iss. 1, 2003-01 ,pp. : 23-29

Elsevier

Access to resources Recommend Favorite

Combination Therapy with a CD4-CDR3 Peptide Analog and Cyclosporin A to Prevent Graft-vs-Host Disease in a MHC-Haploidentical Bone Marrow Transplantation Model

By Townsend R.M.   Gilbert M.J.   Korngold R.  

Clinical Immunology, Vol. 86, Iss. 1, 1998-01 ,pp. : 115-119

Academic Press

Access to resources Recommend Favorite

Synergy of class I and class II MHC deficiency (C1D and C2D) islets and early short-term suppression in achieving long-term islet graft survival and tolerance induction

By Pittman K.   Berzina P.   Contreras J.   Bilbao G.   Thomas F.   Thomas J.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 635-636

Elsevier

Access to resources Recommend Favorite